Physician profile
James J Lyons
NPI 1053306183
$10,263.87
in general payments reported to CMS, 2019-2025
17 companies · $399 in 2025
The $399 reported for 2025 was less than what a typical Advanced Heart Failure and Transplant Cardiology provider received nationally (typical 2025 total: $1,046).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,948 · 2020: $163 · 2021: $187 · 2022: $159 · 2023: $341 · 2024: $66.40 · 2025: $399.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $806.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $806.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $8,370.76 | 2019 | |
| Abbott Laboratories | $1,207.87 | 2019-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Cardiomems |
| Amgen INC. | $125.63 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $87.91 | 2019-2025 | Jardiance |
| Medtronic, INC. | $71.87 | 2023 | Linq II |
| Impulse Dynamics (USA) INC. | $71.56 | 2024-2025 | Optimizer |
| Inari Medical, INC. | $66.71 | 2021 | |
| Bridgebio Pharma, INC. | $60.71 | 2025 | Attruby |
| E.R. Squibb & Sons, L.L.C. | $46.85 | 2019-2025 | Camzyos |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $44.74 | 2025 | Lifevest |
| Pfizer INC. | $28.19 | 2019 | |
| Janssen Pharmaceuticals, INC | $26.04 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $25.46 | 2019 | |
| Sanofi-Aventis U.S. LLC | $15.22 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $14.35 | 2019 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Lyons listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.